Company
United StatesAbbVie Clinical Pharmacology Research Unit (ACPRU), Grayslake, IL – FDA Inspections
Inspection records and compliance data for AbbVie Clinical Pharmacology Research Unit (ACPRU) in Grayslake, Illinois. 2 FDA inspections on record, last inspected January 10, 2020.
Company Profile
This profile covers AbbVie Clinical Pharmacology Research Unit (ACPRU) based in Grayslake, Illinois, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected December 1, 2017. Last inspected January 10, 2020.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 10, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1117577 |
| December 1, 2017 | Not classified | Human Drugs | 1036929 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
AbbVie Clinical Pharmacology Research Unit (ACPRU)
FEI Number
3013956469
Address
480 S Us Highway 45, Grayslake, Illinois 60030, United States
Country
United States
ID: becf4a4a-6a00-4262-ace6-43a8e7a50381